About
Technology
Issues
FAQ
Links
Official Page
Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.